Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to determine the efficacy and safety of clevidipine for treating Hypertensive emergencies(defined as systolic blood pressure >180 mmHg and/or diastolic blood pressure >120 mmHg, accompanied by acute organ damage).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04670809
Study type Interventional
Source Nanjing Yoko Biomedical Co., Ltd.
Contact Yiran Ge
Phone 15298359892
Email geyiran@yoko-bio.com
Status Recruiting
Phase Phase 3
Start date July 27, 2020
Completion date December 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05044364 - Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT02924805 - Telemedical Versus Conventional Emergency Care of Hypertensive Emergencies N/A
Active, not recruiting NCT05155202 - Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit
Not yet recruiting NCT05783557 - A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT04553653 - Improving Acute Hypertension Management Through Emergency Department Checklist N/A
Not yet recruiting NCT05922436 - a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT02672787 - A ED-based Intervention to Improve Antihypertensive Adherence N/A
Not yet recruiting NCT06201572 - The Value of TOI in Evaluating Renal Function Damage in Hypertensive Emergency Patients
Not yet recruiting NCT05139238 - Postpartum Hypertension Study Phase 4
Not yet recruiting NCT06286696 - Optic Nerve Sheath Diameter in Hypertensive Emergency